Member Info for Spikeyj

? - or perhaps more accurately, are expected to have a
decent chance of outperforming over the next few years?

since SMT management are hopefully not so hubristic as to imagine
that all their stock selections will actually outperform. it’s a long game
of average percentages, but there will be a few stinkers in the barrel.

from a long term perspective, 5-10 years , i think the sustained & severe
disruption from covid19 will actually hasten disruptive developments
across many different industries & challenge slower moving traditional
business models from the C20th. the world won’t just be reverting to
the way things were, across multiple sectors including savings & fintech,
biotech/pharma, bigdata/AI, logistics & distribution, energy, advertising
etc. …short term, 2 years say, world will be counting the cost, but covid
has given the world a very big shake like a clumsy toddler juggling a snow
globe, & many of the pieces thrown up in air will settle in different patterns.

lots depend on the timescale that needs to shape an individual’s
investment agenda, and for most folk it’s very sensible to diversify
risk across asset classes, sectors, countries, etc. no-one out there
has an accurate crystal ball. back in my trading days, folks thought
the japanese would take over the world, and tokyo real estate pretty
much outpriced the entire UK economy. but then came two decades
of stagnation, & bye-bye japanese world domination. sensibly, the
outfit i used to work for hedged its bets carefully by working hard to
build up tiny scraps of business, relationships and political capital
with china. it was frustrating slow back in those day (mid/late ‘80s),
but as it transpired, that was v smart seed corn for a different future.

(for comparison, if you recall, osa was very, very excited about
the marginal oil fields bid round — look what became of that
for ADME, and how little he had to say about it afterwards.)

“… both ADME and Zenith are obviously excited by whatever data has been provided …”

some of these AIM CEOs are just pretty good at *pretending* to be
excited at even the most rubbishy ‘asset’, in order to suck pis into a
spike to raise yet more money. we have seen zero evidence of any
kind to back up the idea that barracuda is worth bothering with.

it’s good for the young uns to see these kind of market moves.
hopefully helps folk understand that equity ain’t just easy money.

blimey, a positive note from morgan stanley.

brutal times for poor SMT, a very good reminder indeed of
importance of diversification in portolio - don’t put too many
eggs in one basket! - although even some of the ‘boring’ value
stocks are now down quite a bit compared to 7-10 days ago.

gl all honest folks.

mcco, PWhite73 posted something yesterday at 18:56 over on the other
site relating to the matter of who optima is, & where its money comes from.

(? unless of course there is some kind of connection anyway between the BoD
and optima? - but presumably that can’t possibly be the case, can it, because
otherwise they would have said so transparently, honestly and fully in the
placing RNS, wouldn’t they, given their usual track record of timely, accurate,
comprehensive and clearly phrased communications with the market.)

i wonder why the BoD didn’t put some
more of their own cash into this placing?

dan, circa £500,000 net after the legitimate placing
costs - that would cover their pay & perks until the
start of april, if they didn’t spend on *anything* else.

how much do you think lawyers & courts cost in nigeria?

?odd, ain’t it? — ginksy said “the only placing that could occur is if the
shorters get control of the company by ousting osa.” …. & yet, here’s
another placing straight after the vote, right around the time when i
said they would run out of money if they didn’t do another placing.

presumably, shareholders in ADME can be 100% confident that there were
no additional inducements or compensations of any kind offered to the 1.11p
placee, as if there had been anything of that nature, then it’s absolutely 100%
clear - nay 110%! - that ADME would have been fully open & transparent to the
market about that and would have given full details in the RNS, wouldn’t they?

shareholders can trust them about that, because ADME has demonstrated
a consistently open, honest, transparent approach to business and market
communications, underpinned by high quality good governance, haven’t they?

it keeps ‘em afloat until court hearing,
& maybe until panoro deal proceeds.

monecor must be delighted, eh?

you gotta be kidding?!

re 19:18, personally i’d rather it all came out into the open in the court case(s),
rather than resolved in less transparent ways. sunlight is a good disinfectant.

true, but they are showing a good sustained track record
on innovation & decent governance, which helps reassure
me a bit around the specific leadership risk of the generally
excellent soriot falling under the number 68 yacht one day.

looking for something in the region of £11.75 / £12 by
end 2023, ‘tho i’m baking in the debatable assumption
that they haven’t just overpaid horribly for alexion.

unless a very nasty new variant emerges, i think their oncology sales will pick up pace again nicely in 2022. the vaccine stuff is very laudable imv, but a bit of a distraction from the core biz.

loving the war chest news.

$115 million at 3.1% on 40 year term, kudos, SMT!

if true, that sounds like an additional reason for any sane
pi to run a mile from this stunningly awful can of worms.

(dan, if you’re still invested here, worth a look at some of
the posts over on t’other site about the devious complexity
of who does and doesn’t own what around barracuda. gl.)

$15 million estimate based on what exactly, lol?

? one possible scenario? - purely hypothetical of course:

some parties working with ADME began to incur expenses at barracuda…

…they thought they had undertakings from ADME that
ADME would cough up some money to help fund those
works, drawing on finance from folks like DBI in particular.

… but funnily enough, it turned out that DBI was
not really what is initially seemed to be, & wasn’t
able to produce any meaningful finance for ADME….

… so ADME wasn’t able to pay its way with
those expenses being incurred at barracuda ….

… so some works were halted (such as the CPR?) and some
of those other parties started looking down legal avenues to
pursue cash call(s) that ADME had failed / declined to meet.

my own speculation only, just considering some of
the possibilities. please do feel free to chip in, osa.